Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-23

Clinical Trial Update: A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 real-world study assessing long-term quality of life in adults with psoriasis treated with tildrakizumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tildrakizumab (tildrakizumab)

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2023-02-23